News Releases

• Over 90 leading healthcare companies are scheduled to present
• The conference focuses on Biopharmaceuticals, Biotechnology, Emerging Markets, Healthcare Services, Medical Technology & Devices, and Pharmaceuticals
• Discussions will provide an in-depth look at the overall trends in the healthcare industry, including the impact of industry consolidation, aggressive licensing, and an increased focus in emerging markets

NEW YORK, August 5, 2010 – BMO Capital Markets, the investment and corporate banking arm of BMO Financial Group (TSX, NYSE: BMO), will hold its 10^th annual Focus On Healthcare institutional investor conference today in New York City at the Sheraton New York Hotel and Towers.

More than 400 institutional investors, industry participants and company executives are expected to attend the event, which features a unique line-up of presentations from more than 90 leading public and private healthcare companies.

Some of the presenting public companies include:
• Aetna, Inc. (AET)
• Boston Scientific Corp. (BSX)
• Celgene Corp. (CELG)
• Covidien (COV)
• Eli Lilly & Company (LLY)
• Medco Health Solutions (MHS)
• Merck & Co., Inc. (MRK)
• Pfizer, Inc. (PFE)
• St. Jude Medical (STJ)
• Walgreen (WAG)
• WellPoint, Inc. (WLP)

For a complete list of presenting companies, public and private, visit:
www.bmocm.com/conferences/2010healthcare

BMO’s highly regarded Healthcare Equity Research team will host the conference. The team includes Robert Hazlett (Pharmaceuticals), Dave Shove (Managed Care and Healthcare Services), Joanne Wuensch (Medical Technology) and Jason Zhang (Biotechnology).

Presentations of public companies will be broadcast live and archived at:
www.bmocm.com/conferences/2010healthcare

An agenda with presentation times for the conference is also available on the web site (agenda subject to change). Private companies will not be available on the webcast.

Media interested in attending the conference and/or scheduling an interview may call (416) 867-3996 or toll free at 1-866-298-8385.

About the BMO Capital Markets Healthcare Equity Research Team
The BMO Capital Markets Healthcare Equity Research Team provides coverage of nearly 60 biotechnology, healthcare services, medical technology, and specialty and large-cap pharmaceuticals companies.

About BMO Capital Markets
BMO Capital Markets is a leading, full-service North American financial services provider, with more than 2,200 employees operating in 15 North American offices and 27 worldwide, offering corporate, institutional and government clients access to a complete range of investment and corporate banking products and services. BMO Capital Markets is a member of BMO Financial Group (NYSE, TSX: BMO), one of the largest diversified financial services providers in North America with US$384 billion total assets and 37,000 employees as at April 30, 2010.